Preoperative red cell distribution width in patients undergoing pulmonary resections for non-small-cell lung cancer

European Journal of Cardio-thoracic Surgery

Volumn 45, Issue 1, 2014, Pages 108-113

  Warwick, Richard ^a   Mediratta, Neeraj ^a   Shackcloth, Michael ^a   Shaw, Matthew ^a   McShane, James ^a   Poullis, Michael ^a  

^a LIVERPOOL HEART AND CHEST HOSPITAL   (United Kingdom)

Author keywords

Lung cancer; Mortality; Red cell distribution width; Survival

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; CANCER MORTALITY; CANCER SURGERY; CANCER SURVIVAL; ERYTHROCYTE PARAMETERS; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; LENGTH OF STAY; LONG TERM SURVIVAL; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NONINVASIVE VENTILATION; POSTOPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RED CELL DISTRIBUTION WIDTH; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SURGICAL INFECTION; SURGICAL MORTALITY; THORACOTOMY; VERY ELDERLY; WEDGE RESECTION; YOUNG ADULT;

LUNG CANCER; MORTALITY; RED CELL DISTRIBUTION WIDTH; SURVIVAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARCINOMA, NON-SMALL-CELL LUNG; ERYTHROCYTE INDICES; FEMALE; HOSPITAL MORTALITY; HUMANS; KAPLAN-MEIER ESTIMATE; LENGTH OF STAY; LUNG NEOPLASMS; MALE; MIDDLE AGED; PNEUMONECTOMY; PREOPERATIVE PERIOD; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84890537210     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezt275     Document Type: Article

References (13)

1. Perkins SL. Examination of Blood and Bone Marrow. In: Greer JP, Foerster J, Lukens JN, Rodgers GM, Paraksevas F, Glader BE (eds). Wintrobe's Clinical Hematology. Salt Lake City, Utah: Lippincott Wilkins & Williams 2003, 5-25.
2. Tonelli M, Sacks F, Arnold M, Moye L, Davis B, Pfeffer M. Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease. Circulation 2008;117:163-8.
3. Felker GM, Allen LA, Pocock SJ, Shaw LK, McMurray JJ, Pfeffer MA et al. Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol 2007;50:40-7.
4. Pascual-Figal DA, Bonaque JC, Redondo B, Caro C, Manzano-Fernandez S, Sanchez-Mas J et al. Red blood cell distribution width predicts long-term outcome regardless of anaemia status in acute heart failure patients. Eur J Heart Fail 2009;11:840-6.
5. Poullis M, McShane J, Shaw M, Page R, Shackcloth M, Mediratta N. Framingham risk-based survival of non-small-cell lung cancer. Asian Cardiovasc Thorac Ann 2012;20:30-5.
6. Chalmers J, Mediratta N, McShane J, Shaw M, Pullan M, Poullis M. The long-term effects of developing renal failure post-coronary artery bypass surgery, in patients with normal preoperative renal function. Eur J Cardiothorac Surg 2013;43:555-9.
7. O'Boyle F, Mediratta N, Fabri B, Pullan M, Chalmers J, McShane J et al. Long-term survival after coronary artery bypass surgery stratified by EuroSCORE. Eur J Cardiothorac Surg 2012;42:101-6; discussion 106-7.
8. Duffy TP. Approach to the Patient with Anemia. In: Duffy TP, Kelley WN, Dupont HL, Glick JH, Harris ED, Hathaway DR, Hazzard WR, Holmes EW, Hudson LD, Humes HD, Paty DW (eds). Kelley's Textbook of Internal Medicine. Philadelphia, PA: Lippincott Williams and Wilkins 1997, 1295-9.
9. Falcoz PE, Conti M, Brouchet L, Chocron S, Puyraveau M, Mercier M et al. The Thoracic Surgery Scoring System (Thoracoscore): risk model for in-hospital death in 15,183 patients requiring thoracic surgery. J Thorac Cardiovasc Surg 2007;133:325-32.
10. Jordan S, Mitchell JA, Quinlan GJ, Goldstraw P, Evans TW. The pathogenesis of lung injury following pulmonary resection. Eur Respir J 2000;15:790-9.
11. Hsu CP, Shai SE, Hsia JY, Chen CY. Clinical significance of bone marrow microinvolvement in nonsmall cell lung carcinoma. Cancer 2004;100: 794-800.
12. Ruffato A, Mattioli S, Pileri S, Daddi N, D'Ovidio F, Pilotti V et al. Do bone marrow isolated tumor cells influence long-term survival of non-small cell lung cancer? Eur J Cardiothorac Surg. 2009;35:463-8.
13. Reck M. What future opportunities may immuno-oncology provide for improving the treatment of patients with lung cancer? Ann Oncol 2012;23 (Suppl 8):28-34.